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To the Editor:
I would like to comment on the dis-
cussionamongLimandDusmet,1Marra
and colleagues,2 and Rice and Black-
stone.3There are several issues of confu-
sion; I hope I can clarify some of these.
Sensitivity and specificity are mea-
sures of a test’s inherent diagnostic per-
formance. Sensitivity is the proportion
of patients who test positive among
patients with the disease; specificity is
the proportion of patients who test
negative among patients without the
disease. Another common measure of
diagnostic performance is the receiver
operating characteristic (ROC) curve.4
An ROC curve illustrates a test’s sensi-
tivity and specificity for different crite-
ria for defining positive and negative
test results. For highly accurate tests,
there is a point on the ROC curve that
one can choose if high specificity is de-
sired; the price, however, is low sensi-
tivity. Similarly, one can choose very
high sensitivity but at a price of low
specificity. Lim and Dusmet’s1 com-
ment that ‘‘sensitivity truly starts at
50%’’ is incorrect; a test with low sen-
sitivity (ie,<0.5) can have diagnostic
value if the specificity is high.
Sensitivity and specificity are the
basic measures of a test’s ability, but
they do not describe how well the
test will perform for a particular pa-
tient population. In managing patients,
physicians focus on what the test re-
sults tell them about their patient.
They want to know the probability
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positive test result (positive predictive
value [PPV]) and the probability their
patient does not have the disease after
a negative test result (negative predic-
tive value [NPV]). Predictive values
depend not only on the sensitivity
and specificity of the test but also on
the probability of disease in similar
patients (ie, prevalence of disease). In
fact, when predictive values are reported
in the literature, a subscript indicating
the prevalence rate is often used. For ex-
ample, remediastinoscopy may have an
NPV of 0.85 in a sample with a preva-
lence rate of 0.32, which we write as
NPV0.32 ¼ 0.85. In a different popula-
tion with a different prevalence rate,
the NPV will change, for example,
NPV0.05 ¼ 0.98 or NPV0.50 ¼ 0.72.
Much of the controversy in these au-
thors’ correspondences is due to confu-
sion between sensitivity and PPV, and
between specificity and NPV. Sensitiv-
ity and specificity describe the test’s in-
herent diagnostic abilities irrespective of
the prevalence rate. PPV and NPV, on
the other hand, tell us the likelihood of
disease after the test is performed in
aparticular patient populationwith apar-
ticular prevalence rate. In determining
the role of remediastinoscopy in restag-
ing lung cancer, it seems that PPV and
NPV are the important metrics and
should be the focus of the discussion.
Lim andDusmet1 andMarra and col-
leagues2 point out correctly that speci-
ficity is important for ruling in disease
and sensitivity is important for ruling
out disease. These relationships are
due to the roles of these metrics in esti-
mating PPVs and NPVs. A high speci-
ficity causes the PPV to increase, and
a high sensitivity causes the NPV to
increase, assuming, of course, that the
prevalence of disease is held constant.
As we have illustrated, predictive
values are highly influenced by the
prevalence of disease. Similarly, the
measure of ‘‘accuracy’’ that Marra and
colleagues report is also dependent on
the prevalence of disease in the sample,
and thus could be reported more appro-
priately as overall accuracy0.32 ¼ 0.88.d Cardiovascular Surgery c June 2009There are several other issues in
these correspondences that need clarifi-
cation. First, neither Marra and col-
leagues2 nor Lim and Dusmet1 report
a confidence interval (CI) for specificity.
A reasonable 95% CI for specificity
based on these data is 0.96 to 1.0.5 CIs
for both sensitivity and specificity
should be routinely reported. Contrary
to Marra and colleagues’ description of
the meaning of a CI, it is not ‘‘the likeli-
hood that another sample will provide
the same result.’’ Rather, a CI describes
a range of plausible values for themetric
of interest, here specificity. Statistically
speaking, we expect that 95% of CIs
will contain the real, but unknown,
true value of the metric (ie, specificity);
5% of CIs will not contain the true
value. Statisticians use the data from
a single sample to estimate the unknown
value of the metric; 95% of the time the
CI they construct contains the true
value, although we do not know which
value in the interval it is or which CIs
contain the true value and which do not.
Second, it is important to consider
the effects of patient and disease char-
acteristics in estimating sensitivity
and specificity. For example, the size
of lesions is a critical determinant of
sensitivity, as well as the comorbidities
of patients. Some of the differences
between estimates of sensitivity and
specificity reported in the literature
for remediastinoscopy could be due to
these patient differences.
Third, when a diagnostic test does not
yield a result, that is, the result is ‘‘unin-
terpretable,’’6 it is critical that the fre-
quency of this occurrence be reported.
Marra and colleagues2 reported a 2%
frequency for remediastinoscopy. They
also included this frequency in the de-
nominator of their estimate of overall
accuracy; this gives the reader an honest
estimate of the test’s performance.
Last, I think Drs Rice and Black-
stone’s3 statement that screening tests
usually have good specificity, whereas
a test used to work up patients needs
good sensitivity, is too narrow and
does not describe many scenarios. In
screening for breast cancer, for
ular hypertrophyusingyounggoats aged
4 to 8weeks to achieve right (subpulmo-
nary) ventricular retraining by means of
a balloon catheter or an adjustable pul-
monary artery banding system.1-3 We
have consistently found a hypertrophic
response of the cardiomyocytes. More-
over, we have also demonstrated that
the right ventricle responds not only
with hypertrophy of the myocardial fi-
bers but alsowith hyperplasia of the con-
tractile and interstitial components of the
myocardium.3 Recently, Leeuwenburgh
and colleagues4 demonstrated the devel-
opmentofahyperplastic rather thanahy-
pertrophic myocardial response in
young animals submitted to chronic
right ventricular pressure overload.
Their findings deserve some comments
because previous studies also showed
a hypertrophic response, even in young
animals.Anversa and associates,5 study-
ing 30 normal Wistar rats at 1, 5, and 11
days of age, found that left ventricular
cardiomyocytes presented both hyper-
trophy and hyperplasia, attributing these
to the physiologic pressure overload im-
posed on that chamber after birth.
Based on the age of the lambs (2–3
weeks), the duration of pressure over-
load (8-week period), and the reported
data from the study by Leeuwenburgh
and colleagues,4 we are surprised about
the fact that the authors did not find any
signal of myocardial fiber hypertrophy.
Moreover, even considering the hyper-
plastic response alone, no mention was
myocytes under 2 different protocols
of ventricular systolic overload (contin-
uous and intermittent).3
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CLAMPING THE MITRAL AND
Letters to the Editorexample, physicians look for tests with
good sensitivity even if the false-positive
rate is a bit high. Computer-aided detec-
tion systems are often used to improve
sensitivity, usually at a cost of even
higher recall rates. Without reasonable
sensitivity, many screening programs
cannot be cost-effective. Furtherworkup
of these patients demands higher speci-
ficity to prevent unnecessary invasive
testing. The consequences of test errors
and prevalence of disease must be
weighed in each application to find the
best test for a particular application.
Nancy A. Obuchowski, PhD
Department of Quantitative
Health Sciences
Cleveland Clinic
Cleveland, Ohio
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VENTRICULAR PRESSURE
OVERLOAD IN YOUNG
ANIMALS INDUCES
CARDIOMYOCYTE
HYPERTROPHY IN ADDITION
TO HYPERPLASIA OF
CONTRACTILE AND
NONCONTRACTILE
ELEMENTS OF THE
MYOCARDIUM
To the Editor:
Since the early 1990s, we have been
workingwith experimental right ventric-
made regarding the presence or absence
of proliferating (proliferating cell nu-
clear antigen–labeled) interstitial cells.
If, as the authors stated, ‘‘more of the
same tissue’’ was found in the trained
myocardium, in addition to proliferat-
ing cardiomyocytes, they should have
found some hyperplasia of cells from
the interstitial compartment of the heart.
In fact, this was a prominent feature of
our experimental model of pressure
overload in young animals.3 The num-
ber of interstitial and vessel cells labeled
by the cell proliferation marker Ki67 in
our study was 14 and 18 times greater,
respectively, than that of the cardio-
TRICUSPID ANNULI WITH
BIPOLAR DEVICES
To the Editor:
Castella and colleagues’ article1
reports evidence collected by ap-
plication of a bipolar radiofrequency
clamp on 8 explanted hearts and post-
mortem analysis of 1 patient who died
hours after surgery. The authors unveil
2 main findings: They state it is not pos-
sible to clamp across the mitral annulus
because of the increased thickness of
the atrioventricular (AV) groove, re-
lated to the superimposition of the ven-
tricular mass and fat tissue. They also
claim that, although feasible, clamping
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